Biomerica Stock to Reverse Split on Monday, April 21st (NASDAQ:BMRA)

Biomerica, Inc. (NASDAQ:BMRA) shares are scheduled to reverse split on the morning of Monday, April 21st. The 1-8 reverse split was announced on Wednesday, April 16th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, April 18th.

Biomerica Price Performance

BMRA opened at $0.42 on Thursday. The company has a market capitalization of $7.70 million, a price-to-earnings ratio of -1.24 and a beta of 0.37. The business’s 50-day moving average price is $0.66 and its two-hundred day moving average price is $0.47. Biomerica has a 1 year low of $0.24 and a 1 year high of $1.27.

Biomerica (NASDAQ:BMRA) last posted its quarterly earnings data on Monday, April 14th. The company reported ($0.06) earnings per share (EPS) for the quarter. Biomerica had a negative return on equity of 90.19% and a negative net margin of 100.52%. The firm had revenue of $1.12 million for the quarter.

Institutional Trading of Biomerica

An institutional investor recently raised its position in Biomerica stock. Granahan Investment Management LLC boosted its holdings in Biomerica, Inc. (NASDAQ:BMRA) by 24.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 658,767 shares of the company’s stock after purchasing an additional 131,306 shares during the period. Granahan Investment Management LLC owned about 3.59% of Biomerica worth $198,000 as of its most recent filing with the Securities and Exchange Commission. 22.28% of the stock is currently owned by institutional investors and hedge funds.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.